ALX ONCOLOGY

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer. It is an independent, private biotechnology company. The founding of Alexo Therapeutics was based upon technology invented by Aaron Ring, K. Christopher Garcia, Kipp Weiskopf, Aron Levin, and Irving Weissman at Stanford University. This discovery involves soluble versions of signal regulatory protein-α (SIRPα) that have been engineered to bind CD47 with significantly greater affinity than natural SIRPα.1.

#People #Financial #Website #More

ALX ONCOLOGY

Social Links:

Twitter

Industry:

Biopharma Biotechnology Health Care Life Science Therapeutics

Founded:

2015-01-01

Address:

San Francisco, California, United States

Country:

United States

Website Url:

http://www.alxoncology.com

Total Employee:

11+

Status:

Active

Contact:

(353) 161-8000

Email Addresses:

[email protected]

Total Funding:

166 M USD

Technology used in webpage:

Google Apps For Business Google Maps Google GStatic Google Static Content Google Maps API Google Cloud Google Cloud Oregon Dyn DNS

Current Advisors List

k-christopher-garcia_image

K. Christopher Garcia Board Observer @ ALX Oncology
Board_observer

nathan-caffo_image

Nathan Caffo Strategic Advisor @ ALX Oncology
Advisor
2020-09-01

Current Employees Featured

jaume-pons_image

Jaume Pons
Jaume Pons President, Chief Executive Officer and Co-Founder @ ALX Oncology
President, Chief Executive Officer and Co-Founder

hong-i-wan_image

Hong I. Wan
Hong I. Wan Chief Scientific Officer @ ALX Oncology
Chief Scientific Officer
2017-06-01

john-borgeson_image

John Borgeson
John Borgeson Chief Financial Officer @ ALX Oncology
Chief Financial Officer

sophia-randolph_image

Sophia Randolph
Sophia Randolph Chief Medical Officer @ ALX Oncology
Chief Medical Officer
2016-01-01

michael-chang_image

Michael Chang
Michael Chang Vice President, Operations @ ALX Oncology
Vice President, Operations
2015-01-01

janet-sim_image

Janet Sim
Janet Sim Vice President, Protein Science @ ALX Oncology
Vice President, Protein Science
2018-07-01

hank-stern_image

Hank Stern
Hank Stern Vice President, Chemistry, Manufacturing, and Controls @ ALX Oncology
Vice President, Chemistry, Manufacturing, and Controls
2015-01-01

Founder

jaume-pons_image

Jaume Pons

Stock Details

Company's stock symbol is NASDAQ:ALXO

Acquisitions List

Date	Company	Article	Price
2021-10-07	ScalmiBio	ScalmiBio acquired by ALX Oncology	4.5 M USD

Investors List

cormorant-asset-management_image

Official Site Inspections

http://www.alxoncology.com Semrush global rank: 1.12 M Semrush visits lastest month: 28.58 K

Host Informations
Whois Informations

Loading ...